Common use
Fluorouracil (5-FU) is a potent antimetabolite medication used in topical chemotherapy and systemic cancer treatment. When you buy fluorouracil online, you access a proven treatment for actinic keratosis (precancerous skin lesions) and superficial basal cell carcinoma when applied as a topical cream — commonly known by the brand name Efudex. As a systemic agent, fluorouracil is also used to treat various types of cancer, including colorectal, breast, stomach, and pancreatic cancers. The medication works by interfering with the synthesis of DNA and RNA in rapidly dividing cells, effectively preventing cancer cell growth and replication. Topical fluorouracil specifically targets and destroys precancerous lesions and superficial skin cancer cells while leaving healthy surrounding tissue largely unaffected. This targeted approach to topical chemotherapy makes 5-FU one of the most widely prescribed treatments for actinic keratosis and early-stage skin cancer worldwide.

Dosage and direction
The dosage and administration of fluorouracil depend on the condition being treated, the route of administration, and individual patient factors. For topical chemotherapy of actinic keratosis and precancerous lesions, the cream is typically applied once or twice daily to affected areas for two to four weeks, though treatment duration may vary based on lesion response. When treating superficial basal cell carcinoma, longer treatment courses may be necessary. The Efudex generic cream should be applied in a thin layer using a non-metallic applicator or fingertip (with thorough hand-washing afterward) to avoid spreading the medication to unintended areas. For systemic cancer treatment, fluorouracil is usually administered intravenously in carefully calculated cycles based on body surface area, allowing the body time to recover between treatments. Never adjust your dose of 5-FU without medical supervision, as both under-dosing and overdosing carry significant risks.

Precautions
Before using fluorouracil, inform your doctor if you have bone marrow suppression, active infections, liver dysfunction, or dihydropyrimidine dehydrogenase (DPD) deficiency — a genetic condition that prevents proper breakdown of 5-FU and can lead to life-threatening toxicity. When using topical fluorouracil for actinic keratosis or skin cancer treatment, expect the treated areas to become red, inflamed, and possibly crusted; this inflammatory response is a normal and expected part of the healing process. Avoid contact with people who are sick or have recently received live vaccines, particularly during systemic treatment when your immune system may be compromised. Use thorough sun protection including broad-spectrum sunscreen, protective clothing, and hats, especially when using topical fluorouracil, as the treated skin becomes significantly more sensitive to ultraviolet radiation. Do not apply topical 5-FU near the eyes, nostrils, or mouth unless specifically directed by your dermatologist. Women of childbearing age must use effective contraception during treatment and for a period afterward.

Contraindications
Fluorouracil is contraindicated in patients with known hypersensitivity to the drug or any of its components, marked bone marrow suppression, or severe active infections. It absolutely should not be used in individuals with confirmed DPD enzyme deficiency, as even standard doses may cause life-threatening toxicity including severe mucositis, neutropenia, and neurotoxicity. Topical use of fluorouracil is not recommended on open wounds, deeply ulcerated lesions, or mucous membranes, as increased absorption through damaged skin can lead to systemic side effects. Use in pregnancy is strictly contraindicated due to well-documented potential for severe harm to the developing fetus, including birth defects and fetal death. Breastfeeding during fluorouracil treatment is also not recommended. Patients with severely compromised nutritional status may be at increased risk of serious toxicity from systemic 5-FU therapy.

Possible side effect
Common side effects of systemic fluorouracil include nausea, vomiting, diarrhea, mouth sores (mucositis), and fatigue. With topical chemotherapy for actinic keratosis or basal cell carcinoma, skin reactions such as intense redness, peeling, crusting, burning sensation, and irritation are expected and indicate that the medication is working against precancerous lesions and abnormal cells. Some patients using topical 5-FU may experience increased skin sensitivity, pain at the application site, or temporary changes in skin pigmentation. Serious side effects of systemic treatment include bone marrow suppression leading to increased infection risk, heart toxicity (cardiotoxicity), hand-foot syndrome, and severe gastrointestinal damage. Immediate medical attention is necessary if you develop signs of infection such as fever, chest pain, unusual bleeding or bruising, persistent diarrhea, or symptoms of dehydration. Report any unexpected or severe skin reactions during topical fluorouracil treatment to your dermatologist.

Drug interaction
Fluorouracil may interact with several medications, requiring careful monitoring. Warfarin (a blood thinner) combined with 5-FU can significantly increase the risk of bleeding, necessitating more frequent INR monitoring. Phenytoin levels may be elevated when used alongside fluorouracil, potentially increasing seizure medication side effects. Other chemotherapy drugs used in combination regimens may compound bone marrow suppression and gastrointestinal toxicity. Leucovorin (folinic acid) is sometimes intentionally combined with fluorouracil to enhance its anticancer effect, but this also increases toxicity risk and requires expert oncological supervision. Avoid live vaccines during systemic fluorouracil treatment due to immunosuppression and the risk of vaccine-related infections. Always inform your doctor about all other medications, supplements, and herbal products you are using before starting 5-FU therapy.

Missed dose
If a scheduled intravenous dose of fluorouracil is missed, contact your healthcare provider immediately for instructions — do not attempt to compensate by taking double doses. For topical chemotherapy, apply the missed dose as soon as you remember unless it is close to the time of your next scheduled application, in which case simply continue with your regular treatment schedule. Consistent application of topical fluorouracil is important for achieving optimal results against actinic keratosis and precancerous lesions. Follow your treatment plan closely for the best therapeutic outcome.

Overdose
Symptoms of fluorouracil overdose may include severe nausea, vomiting, gastrointestinal bleeding, overwhelming infection due to bone marrow suppression, and painful mouth sores. Overdose of 5-FU can be life-threatening and requires immediate emergency medical attention. Treatment may involve hospitalization, intensive supportive care, blood transfusions, and administration of growth factors to stimulate white blood cell recovery. While there is no traditional specific antidote, uridine triacetate (Vistogard) has been approved for emergency treatment of severe fluorouracil toxicity cases and should be administered as early as possible for maximum benefit.

Storage
Store fluorouracil injection as directed by your healthcare provider, typically in a refrigerated environment protected from light. Topical fluorouracil cream (Efudex generic) should be stored at room temperature between 20°C and 25°C (68°F to 77°F), away from excessive heat and direct light. Do not freeze any formulation. Keep all fluorouracil products out of reach of children and pets due to the medication’s potency. Do not use after the expiration date or if the product has changed color, consistency, or appearance. When you buy fluorouracil online, inspect the packaging upon delivery to ensure product integrity.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.